טוען...
Dose‐escalation strategies which use subgroup information
Dose‐escalation trials commonly assume a homogeneous trial population to identify a single recommended dose of the experimental treatment for use in future trials. Wrongly assuming a homogeneous population can lead to a diluted treatment effect. Equally, exclusion of a subgroup that could in fact be...
שמור ב:
| הוצא לאור ב: | Pharm Stat |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2018
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6175353/ https://ncbi.nlm.nih.gov/pubmed/29900666 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1860 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|